Literature DB >> 19464603

Surgical management of melanoma.

Jennifer A Wargo1, Kenneth Tanabe.   

Abstract

Melanoma is an increasing health care problem worldwide. Up to 80,000 cases of melanoma are diagnosed per year and it is the sixth leading cause of cancer death in the United States. The lifetime risk is estimated to be 1 in 75 individuals for the development of melanoma. Surgery remains the mainstay of treatment of melanoma, and in most cases it is curative. Several important surgical issues are discussed in this review, including the extent of surgical margins, Mohs micrographic surgery for melanoma in situ, the use of sentinel lymph node biopsy, the usefulness of lymphadenectomy, isolated limb perfusion, and the role of metastasectomy.

Entities:  

Mesh:

Year:  2009        PMID: 19464603     DOI: 10.1016/j.hoc.2009.03.002

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN: 0889-8588            Impact factor:   3.722


  5 in total

1.  Functional modulation of IGF-binding protein-3 expression in melanoma.

Authors:  Altaf A Dar; Shahana Majid; Mehdi Nosrati; David de Semir; Scot Federman; Mohammed Kashani-Sabet
Journal:  J Invest Dermatol       Date:  2010-04-01       Impact factor: 8.551

Review 2.  Genetic factors in metastatic progression of cutaneous melanoma: the future role of circulating melanoma cells in prognosis and management.

Authors:  A Ireland; M Millward; R Pearce; M Lee; M Ziman
Journal:  Clin Exp Metastasis       Date:  2011-02-11       Impact factor: 5.150

Review 3.  Optimal management of metastatic melanoma: current strategies and future directions.

Authors:  Marta Batus; Salman Waheed; Carl Ruby; Lindsay Petersen; Steven D Bines; Howard L Kaufman
Journal:  Am J Clin Dermatol       Date:  2013-06       Impact factor: 7.403

4.  Complete resection of pulmonary metastatic melanoma.

Authors:  Jae Jun Kim; Jae-Kil Park; Young-Pil Wang
Journal:  Korean J Thorac Cardiovasc Surg       Date:  2011-04-14

5.  Surgery of primary melanomas.

Authors:  Piotr Rutkowski; Marcin Zdzienicki; Zbigniew I Nowecki; Alexander C J Van Akkooi
Journal:  Cancers (Basel)       Date:  2010-05-11       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.